| NDC Code | 58160-809-05 |
|---|
| Package Description | 10 VIAL in 1 CARTON (58160-809-05) > .5 mL in 1 VIAL (58160-809-01) |
|---|
| Product NDC | 58160-809 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Menhibrix |
|---|
| Non-Proprietary Name | Meningococcal Groups C And Y And Haemophilus B Tetanus Toxoid Conjugate Vaccine |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20130903 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125363 |
|---|
| Manufacturer | GlaxoSmithKline Biologicals SA |
|---|
| Substance Name | NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE ANTIGEN; NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN; HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN |
|---|
| Strength | 5; 5; 2.5 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL |
|---|
| Pharmacy Classes | Inactivated Meningococcal Vaccine [EPC],Actively Acquired Immunity [PE],Meningococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Meningococcal Vaccine [EPC],Actively Acquired Immunity [PE],Meningococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
|---|